@article{9dd36bc1c7e449d49ab10d1289dcd5b5,
title = "Prescribing in pregnancy: Navigating risks and benefits",
keywords = "PHARMACOLOGY",
author = "Ruth Dobson and Caroline Ovadia and Joela Mathews and Peter Brex",
note = "Funding Information: RD and PB are on the steering committee for the UK MS Pregnancy Register, which seeks to improve our understanding of the safety of DMT in pregnancy. RD has received honoraria for sitting on advisory boards from Roche and Novartis. She sits on the steering committee for the MINORE and SOPRANINO studies, which are examining the safety of ocrelizumab in pregnancy and breastfeeding. She receives grant support from the UK MS Society, BMA foundation, NIHR, MRC, NMSS, Horne Family Charitable Trust, Biogen, Celgene, and Merck. She has received honoraria for advisory boards and/or educational activities from Biogen, Teva, Sanofi, Merck, Janssen, Novartis, and Roche. CO consults for Mirum Pharmaceuticals. KM reports honoraria for advisory boards/educational activities from Biogen, Roche, Merck, Teva, Novartis, Sanofi. JM has received advisory boards fees from Novartis, Sanofi, Roche and Merck PB has received honoraria for advisory boards and/or educational activities from Merck, Biogen, Roche, MS Academy, Janssen, Sanofi-Genzyme, Teva and MedDay Pharmacuticals. ",
year = "2023",
month = oct,
day = "1",
doi = "10.1136/pn-2023-003812",
language = "English",
volume = "23",
pages = "366--367",
journal = "Practical neurology",
issn = "1474-7758",
publisher = "BMJ Publishing Group",
number = "5",
}